Skip to content
IGIGIG446446446

Drawing based on the label description. No photo yet.

“The 10 mg/12.5 mg tablets are peach, round, biconvex tablets debossed IG on one side and 446 on the other side”

IG 446 pill

Pill with imprint IG 446 is pink, round, 6 mm and has been identified as Lisinopril and Hydrochlorothiazide Tablets 10 mg / 12.5 mg. It is used for high blood pressure and quitting smoking. It is supplied by Aphena Pharma Solutions - Tennessee, LLC.

Lisinopril and Hydrochlorothiazide Tablets 10 mg / 12.5 mg

Imprint
IG 446
Strength
Lisinopril 10 mg / Hydrochlorothiazide 12.5 mg
Used for
High blood pressure and quitting smoking
Color
Pink
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet
Manufacturer
Aphena Pharma Solutions - Tennessee, LLC
Drug class
ACE inhibitor (blood pressure and heart medicine)
NDC
71610-382, 76282-446, 71610-382-30, 71610-382-60, 69097-968, 69097-968-05, 69097-968-07, 69097-968-12, 69097-968-15, 76282-446-90, 76282-446-01, 76282-446-05, 76282-446-10, 50090-6094, 50090-6094-0, 50090-6094-1, 50090-6094-2, 71335-1992, 71335-1992-1, 71335-1992-2, 71335-1992-3, 71335-1992-4, 71335-1992-5, 68071-2291, 68071-2291-9

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Lisinopril and Hydrochlorothiazide Tablets pills and guides

What is Lisinopril and Hydrochlorothiazide Tablets used for?

Lisinopril and Hydrochlorothiazide Tablets is used for high blood pressure and quitting smoking.

Medicine type
ACE inhibitor (blood pressure and heart medicine)
Official uses from the US prescribing label

Lisinopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

These fixed-dose combinations are not indicated for initial therapy (see DOSAGE AND ADMINISTRATION).

In using lisinopril and hydrochlorothiazide tablets, consideration should be given to the fact that an angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that lisinopril does not have a similar risk. (See WARNINGS.)

In considering use of lisinopril and hydrochlorothiazide tablets, it should be noted that Black patients receiving ACE inhibitors have been reported to have a higher incidence of angioedema compared to non-Black. (See WARNINGS, Head and Neck Angioedema.)

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows IG and the other side shows 446.
  • It is pink, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Lisinopril and Hydrochlorothiazide.

Ingredients

Active: Lisinopril, Hydrochlorothiazide

Inactive: Anhydrous Dibasic Calcium Phosphate, Mannitol, Starch, Corn, Magnesium Stearate, Ferric Oxide Yellow, Ferric Oxide Red

Also distributed by

Cipla USA Inc., Exelan Pharmaceuticals, Inc., A-S Medication Solutions, Bryant Ranch Prepack, Nucare Pharmaceuticals,inc.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Lisinopril and Hydrochlorothiazide Tablets pills